Advertisement
Screener

NEXTCURE, INC (NXTC) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3

1.4 / 5 stars · 8/29 Roast Me

NEXTCURE, INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3

NEXTCURE, INC (NXTC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 of $0 for the 3-month period ending 2026-06-30, per its S-4 filed 2026-08-18.

Financial Statements › Notes › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 · last filed 2026-08-18

  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2026-06-30 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2026-03-31 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-12-31 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for the quarter ending 2025-06-30 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2023 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2022 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2021 was $0.00.
  • NEXTCURE, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, transfers out of level 3 for fiscal 2020 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 12 month
2026-06-30$0.00
S-4 · filed 2026-08-18
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
2026-03-31$0.00
10-Q · filed 2026-05-07
$0.00
derived: sum of 2 quarters · filed 2026-08-18
2025-12-31$0.00
derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18
$0.00
S-4 · filed 2026-08-18
2025-09-30$0.00
10-Q · filed 2025-11-05
2025-06-30$0.00
10-Q · filed 2025-08-07
$0.00
derived: sum of 2 quarters · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
derived: sum of 4 quarters · filed 2026-08-18
2025-03-31$0.00
10-Q · filed 2025-05-01
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
derived: sum of 4 quarters · filed 2026-08-18
2024-12-31$0.00
derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18
$0.00
derived: sum of 2 quarters · filed 2026-08-18
$0.00
derived: sum of 3 quarters · filed 2026-08-18
$0.00
S-4 · filed 2026-08-18
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$0.00
derived: sum of 2 quarters · filed 2024-11-07
$0.00
10-Q · filed 2024-11-07
$0.00
derived: sum of 4 quarters · filed 2025-03-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$0.00
10-Q · filed 2024-08-01
$0.00
derived: sum of 3 quarters · filed 2025-03-06
$0.00
derived: sum of 4 quarters · filed 2025-03-06
2024-03-31$0.00
10-Q · filed 2024-05-02
$0.00
derived: sum of 2 quarters · filed 2025-03-06
$0.00
derived: sum of 3 quarters · filed 2025-03-06
$0.00
derived: sum of 4 quarters · filed 2025-03-06
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06
$0.00
derived: sum of 2 quarters · filed 2025-03-06
$0.00
derived: sum of 3 quarters · filed 2025-03-06
$0.00
10-K · filed 2025-03-06
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$0.00
derived: sum of 2 quarters · filed 2023-11-02
$0.00
10-Q · filed 2023-11-02
$0.00
derived: sum of 4 quarters · filed 2024-03-21
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
$0.00
derived: sum of 3 quarters · filed 2024-03-21
$0.00
derived: sum of 4 quarters · filed 2024-03-21
2023-03-31$0.00
10-Q · filed 2023-05-04
$0.00
derived: sum of 2 quarters · filed 2024-03-21
$0.00
derived: sum of 3 quarters · filed 2024-03-21
$0.00
derived: sum of 4 quarters · filed 2024-03-21
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$0.00
derived: sum of 2 quarters · filed 2024-03-21
$0.00
derived: sum of 3 quarters · filed 2024-03-21
$0.00
10-K · filed 2024-03-21
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$0.00
derived: sum of 2 quarters · filed 2022-11-03
$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 4 quarters · filed 2023-03-02
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$0.00
derived: sum of 3 quarters · filed 2023-03-02
$0.00
derived: sum of 4 quarters · filed 2023-03-02
2022-03-31$0.00
10-Q · filed 2022-05-05
$0.00
derived: sum of 2 quarters · filed 2023-03-02
$0.00
derived: sum of 3 quarters · filed 2023-03-02
$0.00
derived: sum of 4 quarters · filed 2023-03-02
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$0.00
derived: sum of 2 quarters · filed 2023-03-02
$0.00
derived: sum of 3 quarters · filed 2023-03-02
$0.00
10-K · filed 2023-03-02
2021-09-30$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2022-08-04
$0.00
10-Q · filed 2022-11-03
$0.00
derived: sum of 4 quarters · filed 2022-08-04
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$0.00
derived: sum of 3 quarters · filed 2022-08-04
$0.00
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$0.00
10-Q · filed 2022-05-05
$0.00
derived: sum of 2 quarters · filed 2022-05-05
$0.00
derived: sum of 3 quarters · filed 2022-05-05
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$0.00
derived: sum of 2 quarters · filed 2022-03-03
$0.00
10-K · filed 2022-03-03
2020-09-30$0.00
10-Q · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Cocrystal Pharma, Inc. (COCP)United States$0.022B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86